Triomics raises $15M Sequence A to automate most cancers scientific trials matching

For most cancers sufferers, medicines administered in scientific trials can assist save or prolong lives. However regardless of hundreds of trials in the US annually, solely 3% to five% of eligible sufferers enroll in investigations of recent remedies. Triomics, a generative AI startup, claims it could actually considerably cut back the time it takes docs to match […]

© 2024 TechCrunch. All rights reserved. For private use solely.